Kim WJ - Search Results

1

Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer.

Kim EJ, Jeong P, Quan C, Kim J, Bae SC, Yoon SJ, Kang JW, Lee SC, Jun Wee J, Kim WJ. Kim EJ, et al. Among authors: kim wj, kim j. Urology. 2005 Jan;65(1):70-5. doi: 10.1016/j.urology.2004.08.005. Urology. 2005. PMID: 15667866

2

GSTT1-null genotype is a protective factor against bladder cancer.

Kim WJ, Kim H, Kim CH, Lee MS, Oh BR, Lee HM, Katoh T. Kim WJ, et al. Among authors: kim h, kim ch. Urology. 2002 Nov;60(5):913-8. doi: 10.1016/s0090-4295(02)01892-7. Urology. 2002. PMID: 12429337

3

Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer.

Li QL, Kim HR, Kim WJ, Choi JK, Lee YH, Kim HM, Li LS, Kim H, Chang J, Ito Y, Youl Lee K, Bae SC. Li QL, et al. Among authors: kim h, kim wj, kim hm, kim hr. Biochem Biophys Res Commun. 2004 Jan 30;314(1):223-8. doi: 10.1016/j.bbrc.2003.12.079. Biochem Biophys Res Commun. 2004. PMID: 14715269

4

Estrogen induction of smooth muscle differentiation of human prostatic stromal cells is mediated by transforming growth factor-beta.

Hong JH, Song C, Shin Y, Kim H, Cho SP, Kim WJ, Ahn H. Hong JH, et al. Among authors: kim h, kim wj. J Urol. 2004 May;171(5):1965-9. doi: 10.1097/01.ju.0000123064.78663.2c. J Urol. 2004. PMID: 15076322

5

Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation.

Jin YH, Jeon EJ, Li QL, Lee YH, Choi JK, Kim WJ, Lee KY, Bae SC. Jin YH, et al. Among authors: kim wj. J Biol Chem. 2004 Jul 9;279(28):29409-17. doi: 10.1074/jbc.M313120200. Epub 2004 May 10. J Biol Chem. 2004. PMID: 15138260 Free article.

6

Association of bladder tumors and GA genotype of -308 nucleotide in tumor necrosis factor-alpha promoter with greater tumor necrosis factor-alpha expression.

Jeong P, Kim EJ, Kim EG, Byun SS, Kim CS, Kim WJ. Jeong P, et al. Among authors: kim cs, kim eg, kim wj, kim ej. Urology. 2004 Nov;64(5):1052-6. doi: 10.1016/j.urology.2004.06.018. Urology. 2004. PMID: 15533517

7

Genetic and epigenetic aspects of bladder cancer.

Kim WJ, Quan C. Kim WJ, et al. J Cell Biochem. 2005 May 1;95(1):24-33. doi: 10.1002/jcb.20412. J Cell Biochem. 2005. PMID: 15759278 Review.

8

RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.

Chi XZ, Yang JO, Lee KY, Ito K, Sakakura C, Li QL, Kim HR, Cha EJ, Lee YH, Kaneda A, Ushijima T, Kim WJ, Ito Y, Bae SC. Chi XZ, et al. Among authors: kim wj, kim hr. Mol Cell Biol. 2005 Sep;25(18):8097-107. doi: 10.1128/MCB.25.18.8097-8107.2005. Mol Cell Biol. 2005. PMID: 16135801 Free PMC article.

9

RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.

Kim WJ, Kim EJ, Jeong P, Quan C, Kim J, Li QL, Yang JO, Ito Y, Bae SC. Kim WJ, et al. Among authors: kim ej, kim j. Cancer Res. 2005 Oct 15;65(20):9347-54. doi: 10.1158/0008-5472.CAN-05-1647. Cancer Res. 2005. PMID: 16230397

10

Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer.

Quan C, Cha EJ, Lee HL, Han KH, Lee KM, Kim WJ. Quan C, et al. Among authors: kim wj. J Urol. 2006 Apr;175(4):1512-6. doi: 10.1016/S0022-5347(05)00659-2. J Urol. 2006. PMID: 16516038

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,108 results

Search Page

Filters